Actively Recruiting
Detecting Changes in Arterial Blood Volume and Cardiac Efficiency
Led by HemoCept Inc. · Updated on 2026-04-13
20
Participants Needed
1
Research Sites
70 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this Pilot Study is to demonstrate the efficacy of the Hemocept device in detecting changes in arterial blood volume and cardiac efficiency.
CONDITIONS
Official Title
Detecting Changes in Arterial Blood Volume and Cardiac Efficiency
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent before any study procedures
- Aged between 18 and 80 years, any gender
- Being treated at the participating healthcare facility
- Requires trans-aortic valve replacement (TAVR)
- Able and willing to provide informed consent and HIPM authorization
- Able and willing to meet all study requirements
You will not qualify if you...
- Pregnant, breastfeeding, or planning pregnancy during the study
- Personal medical history of long QT syndrome
- Personal medical history of cardiac channelopathies
- Personal medical history of seizures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Boulder Heart
Boulder, Colorado, United States, 80303
Actively Recruiting
Research Team
K
Katharine Adkins
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here